FR2562421B1 - Perfectionnements a la therapie par l'interleukine - Google Patents

Perfectionnements a la therapie par l'interleukine

Info

Publication number
FR2562421B1
FR2562421B1 FR858505117A FR8505117A FR2562421B1 FR 2562421 B1 FR2562421 B1 FR 2562421B1 FR 858505117 A FR858505117 A FR 858505117A FR 8505117 A FR8505117 A FR 8505117A FR 2562421 B1 FR2562421 B1 FR 2562421B1
Authority
FR
France
Prior art keywords
interleukin therapy
interleukin
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858505117A
Other languages
English (en)
Other versions
FR2562421A1 (fr
Inventor
Thomas Kissel
Jurg Reinhardt
Henriette Schrank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409127A external-priority patent/GB8409127D0/en
Priority claimed from GB848409126A external-priority patent/GB8409126D0/en
Priority claimed from GB848409125A external-priority patent/GB8409125D0/en
Priority claimed from GB848409128A external-priority patent/GB8409128D0/en
Priority claimed from GB848420381A external-priority patent/GB8420381D0/en
Priority claimed from GB848423701A external-priority patent/GB8423701D0/en
Priority claimed from GB848423700A external-priority patent/GB8423700D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2562421A1 publication Critical patent/FR2562421A1/fr
Application granted granted Critical
Publication of FR2562421B1 publication Critical patent/FR2562421B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR858505117A 1984-04-09 1985-04-02 Perfectionnements a la therapie par l'interleukine Expired FR2562421B1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB848409127A GB8409127D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409126A GB8409126D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409125A GB8409125D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848409128A GB8409128D0 (en) 1984-04-09 1984-04-09 Interleukin therapy
GB848420381A GB8420381D0 (en) 1984-08-10 1984-08-10 Interleukin therapy
GB848423701A GB8423701D0 (en) 1984-09-19 1984-09-19 Interleukin therapy
GB848423700A GB8423700D0 (en) 1984-09-19 1984-09-19 Interleukin therapy

Publications (2)

Publication Number Publication Date
FR2562421A1 FR2562421A1 (fr) 1985-10-11
FR2562421B1 true FR2562421B1 (fr) 1989-02-17

Family

ID=27562708

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858505117A Expired FR2562421B1 (fr) 1984-04-09 1985-04-02 Perfectionnements a la therapie par l'interleukine

Country Status (13)

Country Link
US (1) US4863740A (fr)
JP (1) JPH0665650B2 (fr)
AU (1) AU4094685A (fr)
CH (1) CH668554A5 (fr)
DE (1) DE3512926A1 (fr)
DK (1) DK155085A (fr)
FR (1) FR2562421B1 (fr)
GB (1) GB2157172B (fr)
IL (1) IL74835A0 (fr)
IT (1) IT1199967B (fr)
LU (1) LU85839A1 (fr)
NL (1) NL8501010A (fr)
SE (1) SE8501709L (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
ES2039203T3 (es) * 1985-11-22 1993-09-16 Takeda Chemical Industries, Ltd. Composicion de liposomas.
EP0274219A3 (fr) * 1986-12-04 1988-08-03 Takeda Chemical Industries, Ltd. Composition de liposome contenant de l'interleukine-2 et méthode de sa fabrication
FR2624741B1 (fr) * 1987-12-21 1991-06-28 Pasteur Institut Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire
EP0577146A3 (fr) * 1988-05-16 1994-02-02 NeXstar Pharmaceuticals, Inc. Liposomes couplés sur des hormones
US5258499A (en) * 1988-05-16 1993-11-02 Vestar, Inc. Liposome targeting using receptor specific ligands
EP0366770B1 (fr) * 1988-05-16 1994-02-09 Vestar, Inc. Liposomes accouples a des hormones
AU4525589A (en) * 1988-10-27 1990-05-14 Regents Of The University Of Minnesota Liposome immunoadjuvants containing il-2
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
DK0478715T3 (da) * 1989-06-23 1996-08-05 Liposome Co Inc Målrettede liposomer og fremgangsmåder til liposom-protein-kobling
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5817333A (en) * 1991-10-31 1998-10-06 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing a tricyclic compound
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
US5229109A (en) * 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US5449663A (en) * 1993-06-11 1995-09-12 Bicher; Haim I. Antineoplastic compositions
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6406689B1 (en) 1995-10-03 2002-06-18 Frank W. Falkenberg Compositions and methods for treatment of tumors and metastatic diseases
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
EP1039931B1 (fr) * 1997-12-01 2005-04-27 Fang Fang Anticorps de recombinaison multivalents destines au traitement d'infections dues au rhinovirus humain (hrv)
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
EP1045688A1 (fr) * 1998-01-16 2000-10-25 Biomira Usa Inc. Preparation de lipomatrice
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
CN102151337B (zh) 2000-03-13 2014-03-12 恩根尼公司 调节消化道蛋白表达的组合物和方法
US20040102388A1 (en) * 2000-03-22 2004-05-27 High Katherine A. Modified blood clotting factors and methods of use
WO2003062370A2 (fr) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Proteines multimeres et methodes de production et d'utilisation de ces proteines
US20030044354A1 (en) * 2001-08-16 2003-03-06 Carpenter Alan P. Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
TWI461436B (zh) 2005-11-25 2014-11-21 Kyowa Hakko Kirin Co Ltd 人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法
EP1795540A1 (fr) 2005-11-30 2007-06-13 Imaxio Complexes multiples d'antigènes et d'un adjuvant
US20070248539A1 (en) * 2006-04-24 2007-10-25 Shantha West Inc. AgRM2 antigen
WO2008152446A2 (fr) 2006-11-27 2008-12-18 Patrys Limited Nouvelle cible de peptide glycosylé dans des cellules néoplasiques
ES2571235T3 (es) 2009-04-10 2016-05-24 Kyowa Hakko Kirin Co Ltd Procedimiento para el tratamiento de un tumor sanguíneo que utiliza el anticuerpo anti-TIM-3
JP5694923B2 (ja) 2009-04-27 2015-04-01 協和発酵キリン株式会社 血液腫瘍治療を目的とした抗ＩＬ−３Ｒα抗体
US9556272B2 (en) 2009-11-11 2017-01-31 The Trustees Of The University Of Pennsylvania Anti-TEM1 antibodies and uses thereof
WO2013162748A1 (fr) 2012-04-27 2013-10-31 The Trustees Of The University Of Pennsylvania Variants d'anticorps anti-marqueur 1 endothélial de tumeur (tem1) et leurs utilisations
EP2953970A4 (fr) 2013-02-08 2016-06-29 Misfolding Diagnostics Inc Anticorps anti-transthyrétine et leurs utilisations
US20160152952A1 (en) 2013-06-25 2016-06-02 Temple University-Of The Commonwealth System Of Higher Education Cortical Bone-Derived Stem Cells
WO2017180713A1 (fr) 2016-04-13 2017-10-19 Orimabs Ltd. Anticorps anti-psma et leur utilisation
JPWO2024053742A1 (fr) 2022-09-09 2024-03-14

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles
EP0109861A3 (fr) * 1982-11-23 1986-05-14 Bio-Response Inc. Procédé pour isoler des cellules
WO1985000606A1 (fr) * 1983-07-19 1985-02-14 Takeda Chemical Industries, Ltd. Il-2 humaine et son procede de preparation
US4464461A (en) * 1983-07-22 1984-08-07 Eastman Kodak Company Development of light-sensitive quinone diazide compositions
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
CA1260393A (fr) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes de lipides synthetiques

Also Published As

Publication number Publication date
NL8501010A (nl) 1985-11-01
IT8547939A1 (it) 1986-10-09
GB2157172B (en) 1988-12-29
DK155085A (da) 1985-10-10
AU4094685A (en) 1985-10-17
DK155085D0 (da) 1985-04-03
US4863740A (en) 1989-09-05
FR2562421A1 (fr) 1985-10-11
JPH0665650B2 (ja) 1994-08-24
JPS60243022A (ja) 1985-12-03
IT8547939A0 (it) 1985-04-09
LU85839A1 (fr) 1985-12-16
SE8501709D0 (sv) 1985-04-04
GB2157172A (en) 1985-10-23
IT1199967B (it) 1989-01-05
DE3512926A1 (de) 1985-10-24
CH668554A5 (de) 1989-01-13
GB8508809D0 (en) 1985-05-09
SE8501709L (sv) 1985-10-10
IL74835A0 (en) 1985-07-31

Similar Documents

Publication Publication Date Title
IT1188608B (it) Unita' a tettarella
IT8620090A1 (it) Nuovo coniugato nucleoside-fosfolipide
FR2590194B1 (fr) Mecanisme d'agrafeuse
DE3464322D1 (en) Patient's support
DE3566220D1 (en) Patient's support
FR2580495B1 (fr) Preparation dentaire a base d'emulsanne
FR2570567B1 (fr) Agencement d'hydrophone
FR2565312B1 (fr) Mecanisme d'entrainement de cadenceur
IT1200449B (it) Intensificatore d'immagine a medi-infrarossi
SG45992G (en) A slice amplifier using fet's
PH22526A (en) 2-2' bi-ih-imidazoles
IT1189547B (it) Unita' di impostazione elettroidraulica
SU1268026A1 (ru) Мощный импульсный тиристор
KR860000031U (ko) 탕비기의 푸시버튼식 조작장치
FR2558615B1 (fr) Controleur integre d'unite a disque souple
BR8507317A (pt) Gurinchuk 11)v a
LV5402A3 (lv) Kardioprotektors "Mildonats"
KR860007548U (ko) 프레스의 파이롯드 고정장치
MA20618A1 (fr) Variete clementinier precoce "ripetri"
IT8403550A0 (it) Compressore-generatore a contemporaneita' d'impiego
LV5111A3 (lv) Buvmateriala izgatavosanas panemiens
IT8533604V0 (it) "utility - belt"
IT8511793V0 (it) "stendiarredo"
IT8518814V0 (it) "lava - pentole"
IT8533609V0 (it) "utility-notes"

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse